Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
OFIX
HOLDOrthofix Medical Inc. · Healthcare · United States · $455M · Avg Vol: $4M/d
COMPANY DESCRIPTION
Orthofix Medical Inc. is a global medical device company focused on musculoskeletal products and therapies, including spine fixation, biologics, bone growth therapies, and extremity fixation. The company differentiates itself through a portfolio of clinically proven products and proprietary technologies, particularly in bone growth stimulation and advanced spinal solutions. Orthofix is a specialized medical device company committed to advancing musculoskeletal health through innovative bone and spine solutions.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 460.7M | 746.6M | 799.5M | 822.3M | 21.3% | 825.4M | 843.3M | 885.7M | 3.8% |
| EPS | -0.49 | -4.12 | -3.30 | -2.33 | — | -1.50 | — | — | — |
| Shares | 40.4M | 37.2M | 38.5M | 39.8M | -1.5% | 40.4M | — | — | — |
| Debt | 21.5M | 117.1M | 179.6M | 178.4M | 102.4% | 262.3M | — | — | — |
| Equity | 336.9M | 598.7M | 503.1M | 450.0M | 10.1% | — | — | — | — |
| Op CF | -11.5M | -45.8M | 25.8M | 33.3M | 29.3% | 34.1M | — | — | — |
| Inv CF | -24.5M | -33.1M | -27.6M | -34.6M | — | — | — | — | — |
| Fin CF | -78.0K | 65.3M | 50.7M | -0.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of OFIX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| OFIX | Orthofix Medical Inc.(you) | $455M | 51 | HOLD |
| KIDS | OrthoPediatrics Corp. | $485M | 50 | HOLD |
| VREX | Varex Imaging Corporation | $460M | 56 | HOLD |
| CERS | Cerus Corporation | $587M | 46 | HOLD |
| MASS | 908 Devices Inc. | $293M | 52 | HOLD |
| CTKB | Cytek Biosciences, Inc. | $576M | 40 | HOLD |
| SIBN | SI-BONE, Inc. | $737M | 42 | HOLD |
| NPCE | NeuroPace, Inc. | $505M | 32 | SELL |
| QDEL | QuidelOrtho Corporation | $1.1B | 47 | HOLD |
| INGN | Inogen, Inc. | $167M | 55 | HOLD |
Peer medians: ROE -25.6% · P/E 27.7x · Gross margin 50.5%